CNMD
CONMED Corporation NYSE Listed Jul 23, 1987$38.09
Mkt Cap $1.1B
52w Low $33.21
17.5% of range
52w High $61.08
50d MA $38.13
200d MA $43.98
P/E (TTM)
24.2x
EV/EBITDA
11.6x
P/B
1.1x
Debt/Equity
0.8x
ROE
4.5%
P/FCF
8.4x
RSI (14)
—
ATR (14)
—
Beta
0.99
50d MA
$38.13
200d MA
$43.98
Avg Volume
449.9K
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
11311 Concept Boulevard · Largo, FL 33773-4908 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 0.82 | 0.89 | +8.5% | 35.96 | +3.0% | +1.9% | +0.4% | -2.5% | +2.1% | +1.9% | — |
| Jan 28, 2026 | AMC | 1.32 | 1.43 | +8.3% | 38.69 | +0.2% | -3.6% | +2.9% | +2.1% | -1.1% | +2.9% | — |
| Nov 5, 2025 | AMC | 1.05 | 1.08 | +2.9% | 44.44 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% | — |
| Jul 30, 2025 | AMC | 1.13 | 1.15 | +1.8% | 50.14 | +4.1% | +2.0% | +2.2% | +2.3% | +0.0% | -4.6% | — |
| Apr 30, 2025 | AMC | 0.81 | 0.95 | +17.3% | 49.11 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% | — |
| Feb 5, 2025 | AMC | 1.20 | 1.34 | +11.7% | 74.00 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% | — |
| Oct 30, 2024 | AMC | 0.99 | 1.05 | +6.1% | 65.26 | +0.0% | +4.6% | +3.2% | +0.1% | +5.0% | +2.2% | — |
| Jul 31, 2024 | AMC | 0.91 | 0.98 | +7.7% | 69.04 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% | — |
| Apr 24, 2024 | AMC | 0.74 | 0.79 | +6.8% | 70.01 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% | — |
| Jan 31, 2024 | AMC | 1.11 | 1.06 | -4.5% | 95.60 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% | — |
| Oct 25, 2023 | AMC | 0.83 | 0.90 | +8.4% | 91.68 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% | — |
| Jul 26, 2023 | AMC | 0.79 | 0.83 | +5.1% | 122.63 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $36.66 | $36.94 | +0.8% | +0.4% | -2.5% | +2.1% | +1.9% | +2.1% |
| Apr 30 | JP Morgan | Maintains | Neutral → Neutral | — | $35.96 | $37.04 | +3.0% | +1.9% | +0.4% | -2.5% | +2.1% | +1.9% |
| Mar 17 | Piper Sandler | Downgrade | Overweight → Neutral | — | $37.41 | $37.30 | -0.3% | -0.2% | -1.7% | +0.2% | -2.3% | +1.9% |
| Jan 29 | Needham | Maintains | Hold → Hold | — | $38.69 | $38.77 | +0.2% | -3.6% | +2.9% | +2.1% | -1.1% | +2.9% |
| Jan 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $38.69 | $38.77 | +0.2% | -3.6% | +2.9% | +2.1% | -1.1% | +2.9% |
| Dec 8 | BofA Securities | Maintains | Neutral → Neutral | — | $40.07 | $40.07 | +0.0% | +1.2% | -3.9% | +0.1% | +2.1% | +2.5% |
| Nov 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $44.44 | $43.00 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% |
| Nov 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $44.44 | $43.00 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% |
| Nov 6 | JP Morgan | Maintains | Neutral → Neutral | — | $44.44 | $43.00 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% |
| Jul 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $50.14 | $52.22 | +4.1% | +2.0% | +2.2% | +2.3% | +0.0% | -4.6% |
| Jun 12 | Needham | Downgrade | Buy → Hold | — | $56.95 | $55.39 | -2.7% | -3.5% | -2.6% | -0.3% | -2.1% | -0.3% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.11 | $55.00 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% |
| May 1 | JP Morgan | Maintains | Neutral → Neutral | — | $49.11 | $55.00 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% |
| May 1 | Needham | Maintains | Buy → Buy | — | $49.11 | $55.00 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% |
| Apr 28 | Stifel | Downgrade | Buy → Hold | — | $50.71 | $50.01 | -1.4% | +0.3% | +0.6% | -4.0% | +16.5% | +0.9% |
| Feb 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Feb 6 | Stifel | Maintains | Buy → Buy | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Feb 6 | Needham | Maintains | Buy → Buy | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Feb 6 | JP Morgan | Downgrade | Overweight → Neutral | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | $65.26 | $65.26 | +0.0% | +4.6% | +3.2% | +0.1% | +5.0% | +2.2% |
| Oct 4 | Needham | Maintains | Buy → Buy | — | $66.56 | $68.33 | +2.7% | +0.0% | -3.8% | -0.1% | -1.6% | -1.9% |
| Aug 1 | Stifel | Maintains | Buy → Buy | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Aug 1 | Needham | Maintains | Buy → Buy | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Aug 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Aug 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Jul 25 | Needham | Maintains | Buy → Buy | — | $71.60 | $71.74 | +0.2% | -1.4% | +0.6% | -1.3% | -0.8% | -0.7% |
| May 6 | Needham | Maintains | Buy → Buy | — | $71.76 | $72.08 | +0.4% | -1.4% | +1.3% | -3.1% | +1.4% | +1.2% |
| Apr 25 | Piper Sandler | Maintains | Overweight → Overweight | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Apr 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Apr 25 | JP Morgan | Maintains | Overweight → Overweight | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Apr 25 | Needham | Maintains | Buy → Buy | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Feb 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Feb 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Feb 1 | JP Morgan | Maintains | Overweight → Overweight | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Feb 1 | Needham | Maintains | Buy → Buy | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Oct 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $94.38 | $94.38 | +0.0% | +0.6% | +2.7% | -0.1% | +1.3% | +1.5% |
| Oct 26 | Needham | Maintains | Buy → Buy | — | $91.68 | $94.66 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% |
| Oct 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $91.68 | $94.66 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% |
| Oct 26 | Stifel | Maintains | Buy → Buy | — | $91.68 | $94.66 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% |
| Jul 27 | JP Morgan | Maintains | Overweight → Overweight | — | $122.63 | $133.57 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% |
| Jul 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $122.63 | $133.57 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% |
| Jul 27 | Needham | Maintains | Buy → Buy | — | $122.63 | $133.57 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% |
| Jul 24 | Needham | Maintains | Buy → Buy | — | $122.19 | $122.01 | -0.1% | -0.5% | -1.2% | +2.1% | -3.6% | +0.4% |
| Jun 5 | Needham | Maintains | Buy → Buy | — | $126.81 | $125.69 | -0.9% | -0.9% | +1.1% | +0.9% | +2.8% | +0.6% |
| May 22 | CL King | Maintains | Buy → Buy | — | $118.96 | $119.08 | +0.1% | +1.3% | -1.5% | -2.5% | +1.4% | +0.8% |
| Apr 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | Stifel | Maintains | Buy → Buy | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | Needham | Maintains | Buy → Buy | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
No insider trades available.
8-K
CONMED Corporation -- 8-K Filing
CONMED Corporation reported Q1 2026 sales of $317.0 million, down 1.3% year-over-year, signaling modest revenue headwinds despite operational continuity.
Apr 29
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CONMED's leadership transition on March 13, 2026 creates uncertainty about strategic direction and execution capability, potentially impacting near-term stock performance until new management's vision becomes clear.
Mar 13
Data updated apr 25, 2026 2:14am
· Source: massive.com